These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 11040082

  • 1. Retinal function is improved in a murine model of a lysosomal storage disease following bone marrow transplantation.
    Ohlemiller KK, Vogler CA, Roberts M, Galvin N, Sands MS.
    Exp Eye Res; 2000 Nov; 71(5):469-81. PubMed ID: 11040082
    [Abstract] [Full Text] [Related]

  • 2. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates.
    Sands MS, Barker JE, Vogler C, Levy B, Gwynn B, Galvin N, Sly WS, Birkenmeier E.
    Lab Invest; 1993 Jun; 68(6):676-86. PubMed ID: 8515654
    [Abstract] [Full Text] [Related]

  • 3. AAV-mediated intravitreal gene therapy reduces lysosomal storage in the retinal pigmented epithelium and improves retinal function in adult MPS VII mice.
    Hennig AK, Ogilvie JM, Ohlemiller KK, Timmers AM, Hauswirth WW, Sands MS.
    Mol Ther; 2004 Jul; 10(1):106-16. PubMed ID: 15233947
    [Abstract] [Full Text] [Related]

  • 4. Brain transplantation of genetically modified bone marrow stromal cells corrects CNS pathology and cognitive function in MPS VII mice.
    Sakurai K, Iizuka S, Shen JS, Meng XL, Mori T, Umezawa A, Ohashi T, Eto Y.
    Gene Ther; 2004 Oct; 11(19):1475-81. PubMed ID: 15295619
    [Abstract] [Full Text] [Related]

  • 5. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII.
    Barker JE, Deveau S, Lessard M, Hamblen N, Vogler C, Levy B.
    Blood Cells Mol Dis; 2001 Oct; 27(5):861-73. PubMed ID: 11783949
    [Abstract] [Full Text] [Related]

  • 6. Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer.
    Daly TM, Ohlemiller KK, Roberts MS, Vogler CA, Sands MS.
    Gene Ther; 2001 Sep; 8(17):1291-8. PubMed ID: 11571565
    [Abstract] [Full Text] [Related]

  • 7. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.
    Frisella WA, O'Connor LH, Vogler CA, Roberts M, Walkley S, Levy B, Daly TM, Sands MS.
    Mol Ther; 2001 Mar; 3(3):351-8. PubMed ID: 11273777
    [Abstract] [Full Text] [Related]

  • 8. Effects of bone marrow transplantation on the cardiovascular abnormalities in canine mucopolysaccharidosis VII.
    Sammarco C, Weil M, Just C, Weimelt S, Hasson C, O'Malley T, Evans SM, Wang P, Casal ML, Wolfe J, Haskins M.
    Bone Marrow Transplant; 2000 Jun; 25(12):1289-97. PubMed ID: 10871735
    [Abstract] [Full Text] [Related]

  • 9. Photoreceptor degeneration and altered distribution of interphotoreceptor matrix proteoglycans in the mucopolysaccharidosis VII mouse.
    Lazarus HS, Sly WS, Kyle JW, Hageman GS.
    Exp Eye Res; 1993 May; 56(5):531-41. PubMed ID: 8500564
    [Abstract] [Full Text] [Related]

  • 10. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C, Sands MS, Galvin N, Levy B, Thorpe C, Barker J, Sly WS.
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [Abstract] [Full Text] [Related]

  • 11. Widespread biochemical correction of murine mucopolysaccharidosis type VII pathology by liver hydrodynamic plasmid delivery.
    Richard M, Arfi A, Seguin J, Gandolphe C, Scherman D.
    Gene Ther; 2009 Jun; 16(6):746-56. PubMed ID: 19357715
    [Abstract] [Full Text] [Related]

  • 12. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII.
    Sands MS, Erway LC, Vogler C, Sly WS, Birkenmeier EH.
    Blood; 1995 Sep 01; 86(5):2033-40. PubMed ID: 7655032
    [Abstract] [Full Text] [Related]

  • 13. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival.
    Vogler C, Sands MS, Levy B, Galvin N, Birkenmeier EH, Sly WS.
    Pediatr Res; 1996 Jun 01; 39(6):1050-4. PubMed ID: 8725268
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Histopathological and behavioral improvement of murine mucopolysaccharidosis type VII by intracerebral transplantation of neural stem cells.
    Fukuhara Y, Li XK, Kitazawa Y, Inagaki M, Matsuoka K, Kosuga M, Kosaki R, Shimazaki T, Endo H, Umezawa A, Okano H, Takahashi T, Okuyama T.
    Mol Ther; 2006 Mar 01; 13(3):548-55. PubMed ID: 16316785
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain.
    Snyder EY, Taylor RM, Wolfe JH.
    Nature; 1995 Mar 23; 374(6520):367-70. PubMed ID: 7885477
    [Abstract] [Full Text] [Related]

  • 20. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
    Gao C, Sands MS, Haskins ME, Ponder KP.
    Mol Ther; 2000 Sep 23; 2(3):233-44. PubMed ID: 10985954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.